Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2

4(50.0%)

N/A

3(37.5%)

Phase 3

1(12.5%)

8Total

Phase 2(4)

N/A(3)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT03788759Phase 2Completed

Alpha-lipoic Acid Adjunctive Therapy in Schizophrenia

Role: lead

NCT04384458Not ApplicableUnknown

Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis

Role: lead

NCT04473352Unknown

COVID-19 Detection Tests in Different Body Fluids

Role: lead

NCT04391582Phase 2Completed

Pediatric Burn Treatment Using Tilapia Skin as a Xenograft for Superficial-Partial Thickness Wounds

Role: lead

NCT04202289Phase 3Completed

Use of Nile Tilapia Fish Skin as a Xenograft for Burn Treatment: Phase III Study

Role: lead

NCT03790345Phase 2Unknown

Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics

Role: lead

NCT03592498Phase 2Completed

Study to Evaluate the Use of Tilapia Skin (Oreochromis Niloticus), in the Treatment of Burn Wounds

Role: lead

NCT03588273Not ApplicableCompleted

Effect of Stomach Reduction Surgery on the Parameters of Amoxicillin

Role: lead

NCT02926885Not ApplicableCompleted

Efficacy Evaluation of the Esophagogastric Junction Exposure Obtained by the Flexible Liver Retractor in Gastroplasty

Role: lead

All 9 trials loaded